Shopping Cart
- Remove All
- Your shopping cart is currently empty
Azelaprag (Example 263.0) is a candidate active molecule (EC50= 0.32 nM) for an apelin receptor agonist. Azelaprag can be used to treat nervous system diseases, cardiovascular diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $107 | In Stock | |
5 mg | $263 | In Stock | |
10 mg | $413 | In Stock | |
25 mg | $712 | In Stock | |
1 mL x 10 mM (in DMSO) | $336 | In Stock |
Description | Azelaprag (Example 263.0) is a candidate active molecule (EC50= 0.32 nM) for an apelin receptor agonist. Azelaprag can be used to treat nervous system diseases, cardiovascular diseases. |
Targets&IC50 | RAGE:12.7 ± 7.6 nM (kd), apelin receptor:0.32 nM (EC50) |
In vivo | METHODS: To investigate the effect of Azelaprag on cardiac function, Azelaprag (1mg/kg/min) was infused intravenously at an acute time point in a rat model of impaired metabolic function. RESULTS: Azelaprag increased cardiac reserve during Dobutamine challenge in a metabolically impaired rat model. [1] |
Synonyms | AMG 986 |
Molecular Weight | 523.61 |
Formula | C25H29N7O4S |
Cas No. | 2049980-18-7 |
Smiles | N(S([C@H]([C@H](C)C=1N=CC(C)=CN1)C)(=O)=O)C=2N(C(=NN2)C=3C=C(C)C=NC3)C4=C(OC)C=CC=C4OC |
Relative Density. | 1.35 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (114.59 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.